Embed Size (px)
Citation preview
•Possible topic/topics
•(edit)
•Keywords
•(edit)
Sena NOMAK
Co-Founder, Chief Operating Officer
RS RESEARCH (SME)
Better Health and Care
Organization
Partner of H2020
MSCA-RISE Project (PANG)
(2016 – 2019)
2010 Research started Bogazici University
Q1 2015 Company Founded
Funding received 2 M Euro – ACT VC Q2 2017
Phase-I Trial RS-0139 Q3 2019
Q2 2020 Phase-I Trial RS-0337
Q2 2018 Switzerland HQ Biopôle
Looking for strategic partners
to collaborate
In water
Low Risk Business Model: Prodrugs from clinically proven chemo agents Novel Product: Proprietary nanocarrier-linker-drug combination Targeted chemotherapy Protected with platform patents and FTO Superior Results: Improved side effect profile Increased efficacy
Our project idea: Clinical Trials for Curing Cancer with Targeted Therapies
SC1-BHC-08-2020: New interventions for Non-Communicable Diseases
https://rsresearch.net/pipeline/
Contact details
• Sena Nomak
• RS Research - https://rsresearch.net/
• Teknopark Istanbul, Sanayi Mah. Teknopark Blv. 2C-2014, Pendik, Istanbul, Turkey
• +90 530 760 67 62
Sena Nomak Co-Founder,
Rana Sanyal Co-Founder, CSO [email protected]
We are open for collaboration with;
- Clinical Trial Centers
- Good Manufacturing Practices (GMP) facilities
- Good Laboratory Practices (GLP) labs
for our investigational medicinal products.
